HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice.

Abstract
This unit provides detailed protocols for establishing rodent models of L-DOPA-induced dyskinesia. The 6-hydroxydopamine (6-OHDA) lesion procedure is described in more detail for mice than for rats since the lesioning procedure in rats has been described extensively in previous work and is less difficult to perform. Unlike primate models, rodent models of L-DOPA-induced dyskinesia are relatively simple and fast to set up, thus being affordable to most laboratories. These models allow for studying the dyskinetic complications of L-DOPA treatment on large groups of animals under strictly controlled experimental conditions. Along with information and structured protocols for the practical execution of the test, this unit provides a detailed description of the rating scale and the phenomenology of rodent abnormal involuntary movements, and suggestions for beginners.
AuthorsM Angela Cenci, Martin Lundblad
JournalCurrent protocols in neuroscience (Curr Protoc Neurosci) Vol. Chapter 9 Pg. Unit 9.25 (Oct 2007) ISSN: 1934-8576 [Electronic] United States
PMID18428668 (Publication Type: Journal Article)
CopyrightCopyright 2007 by John Wiley & Sons, Inc.
Chemical References
  • Antiparkinson Agents
  • Sympatholytics
  • Levodopa
  • Oxidopamine
Topics
  • Animals
  • Antiparkinson Agents (toxicity)
  • Disease Models, Animal
  • Dyskinesia, Drug-Induced (physiopathology)
  • Levodopa (toxicity)
  • Mice
  • Oxidopamine (toxicity)
  • Parkinsonian Disorders (chemically induced, drug therapy, physiopathology)
  • Rats
  • Sympatholytics (toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: